Michael Wolff Jensen

Largest profit: TECH GROWTH INVEST ApS (2017) '143,475 DKK

Most equity: TECH GROWTH INVEST ApS (2017) '365,498 DKK

Biggest loss: TECH GROWTH INVEST ApS (2016) '222,024 DKK

• Ascendis Pharma Oncology Division A/S

  Active

  
  

  Board member (2019-12-13 - present)

• Ascendis Pharma Endocrinology Division A/S

  Active

  
  

  Board member (2012-06-29 - present)

• TECH GROWTH INVEST ApS

  Active

  
  

  Director (2000-05-18 - 2001-06-28)

• Custimoo ApS

  Active

  
  

  Board member (2019-03-07 - 2019-06-30)

• Ascendis Pharma Nordics A/S

  Inactive

  
  

  Board member (2023-10-05 - 2024-12-05)

• FP Consult v/Michael Wolff Jensen

  Inactive

  
  

  Legal owner (2000-06-01 - 2013-08-31)

• PARADIS INTERNATIONAL A/S

  Inactive

  
  

  Board member (2008-09-10 - 2010-02-09)

• Ascendis Pharma Growth Disorders A/S

  Active

  
  

  Board member (2012-06-29 - present)

• MIWO Invest ApS

  Active

  
  

  Director (2014-01-28 - present)

  Legal owner (2014-01-28 - present) 100% ownership (2014-01-28 – ) 100% voting rights (2014-01-28 – )

  Ultimate beneficial owner (2014-01-28 - present) 100% ownership (2014-01-28 – ) 100% voting rights (2014-01-28 – )

• VANX ApS

  Active

  
  

  Board member (2018-02-12 - 2019-06-30)

  Board member (2016-11-16 - 2018-02-06)

• ASCENDIS PHARMA BONE DISEASES A/S

  Active

  
  

  Board member (2012-06-29 - present)

• ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S

  Active

  
  

  Board member (2012-06-29 - present)